Advertisement

Intracranial Stenting for Symptomatic Intracranial Stenosis

  • Travis M. Dumont
  • Maxim Mokin
  • Peter Kan
  • Elad I. Levy
Chapter

Abstract

Intracranial stenting presents an option for the treatment of symptomatic intracranial stenosis refractory to medical treatment. Intracranial stenosis accounts for up to 10 % of ischemic strokes and represents a very morbid disease, with an expected 1-year stroke or death rate in excess of 12 % and as high as 23 %, despite medical treatment with appropriate antiplatelet or anticoagulant medication. Surgical treatment with extracranial-to-intracranial bypass, although technically successful in restoring blood flow to a diseased vessel, has not been shown to effectively reduce ischemic events. Endovascular treatment with intraluminal revascularization has been shown to be an effective alternate technique for such lesions.

Keywords

Dual Antiplatelet Therapy Guide Catheter Intracranial Stenosis P2Y12 Reaction Unit Distal Access 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

ACT

Activated coagulation time

AP

Anteroposterior

ARU

Aspirin reaction unit

atm

Atmosphere

CT

Computed tomographic

F

French

FDA

Food and Drug Administration

ICA

Internal carotid artery

MCA

Middle cerebral artery

MR

Magnetic resonance

PTA

Percutaneous transluminal angioplasty

SAMMPRIS

Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis

TIA

Transient ischemic attack

VA

Vertebral artery

VISSIT

Vitesse Intracranial Stent Study for Ischemic Therapy

WASID

Warfarin–Aspirin Symptomatic Intracranial Disease

References

  1. 1.
    Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003.PubMedCrossRefGoogle Scholar
  2. 2.
    Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–16.PubMedCrossRefGoogle Scholar
  3. 3.
    Powers WJ, Clarke WR, Grubb Jr RL, Videen TO, Adams Jr HP, Derdeyn CP. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA. 2011;306:1983–92.PubMedCrossRefGoogle Scholar
  4. 4.
    EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med. 1985;313:1191–200.CrossRefGoogle Scholar
  5. 5.
    SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke. 2004;35:1388–92.CrossRefGoogle Scholar
  6. 6.
    Jiang WJ, Xu XT, Jin M, Du B, Dong KH, Dai JP. Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR Am J Neuroradiol. 2007;28:830–4.PubMedGoogle Scholar
  7. 7.
    Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke. 2005;36:e165–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Freitas JM, Zenteno M, Aburto-Murrieta Y, Koppe G, Abath C, Nunes JA, et al. Intracranial arterial stenting for symptomatic stenoses: a Latin American experience. Surg Neurol. 2007;68:378–86.PubMedCrossRefGoogle Scholar
  9. 9.
    Kurre W, Berkefeld J, Sitzer M, Neumann-Haefelin T, du Mesnil de Rochemont R. Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience. Neuroradiology. 2008;50:701–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Qureshi AI, Kirmani JF, Hussein HM, Harris-Lane P, Divani AA, Suri MF, et al. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery. 2006;59:1044–51.PubMedCrossRefGoogle Scholar
  11. 11.
    Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke. 2007;38:881–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Fiorella DJ, Turk AS, Levy EI, Pride Jr GL, Woo HH, Albuquerque FC, et al. U.S. Wingspan Registry: 12-month follow-up results. Stroke. 2011;42:1976–81.PubMedCrossRefGoogle Scholar
  13. 13.
    Dumont TM, Kan P, Snyder KV, Hopkins LN, Siddiqui AH, Levy EI. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study. Neurosurgery 2012;71:1103–10.PubMedCrossRefGoogle Scholar
  14. 14.
    Chamczuk AJ, Ogilvy CS, Snyder KV, Ohta H, Siddiqui AH, Hopkins LN, et al. Elective stenting for intracranial stenosis under conscious sedation. Neurosurgery. 2010;67:1189–94.PubMedCrossRefGoogle Scholar
  15. 15.
    Levy EI, Hanel RA, Bendok BR, Boulos AS, Hartney ML, Guterman LR, et al. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg. 2002;97:1294–301.PubMedCrossRefGoogle Scholar
  16. 16.
    Levy EI, Howington JU, Engh JA, Hanel RA, Levy N, Kim SH, et al. Submaximal angioplasty and staged stenting for severe posterior circulation intracranial stenosis: a technique in evolution. Neurocrit Care. 2005;2:189–97.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Travis M. Dumont
    • 1
    • 2
  • Maxim Mokin
    • 1
    • 2
    • 4
  • Peter Kan
    • 2
    • 3
  • Elad I. Levy
    • 2
    • 5
    • 6
  1. 1.Department of Neurosurgery, School of Medicine and Biomedical SciencesUniversity at Buffalo, State University of New YorkTampaUSA
  2. 2.Department of NeurosurgeryGates Vascular Institute, Kaleida HealthTampaUSA
  3. 3.Department of NeurosurgeryTampa General HospitalTampaUSA
  4. 4.Department of NeurosurgeryUniversity at Buffalo NeurosurgeryBuffaloUSA
  5. 5.Department of Neurosurgery and Department of Radiology, School of Medicine and Biomedical SciencesUniversity at Buffalo, State University of New YorkTampaUSA
  6. 6.Toshiba Stroke Research Center, School of Medicine and Biomedical SciencesUniversity at Buffalo, State University of New YorkTampaUSA

Personalised recommendations